Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial.

Authors: Sven G. Meuth, Thomas Henze, Ute Essner, Christiane Trompke, Carlos Vila Silván Published in International Journal of Neuroscience Abstract Objective: To determine whether differences in disability status, spasticity severity,…

Factors Moderating the Association Between Cannabis Use and Psychosis Risk: A Systematic Review.

Authors: Sanne J. van der Steur, Albert Batalla, Matthijs G. Bossong Published in Brain Sciences 12 February 2020   Abstract Increasing evidence indicates a relationship between cannabis use and psychosis…

Lifetime Average Cannabis Use in Relation to Hypertriglyceridemic Waist Phenotype in U.S. Adults: A Population-Based Cross-Sectional Study

Authors: Gerard Ngueta Published in Cannabis and Cannabinoid Research 11 February 2020   Abstract Background and Aims: With a growing number of states legalizing recreational or medical cannabis, prevalence of…

Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients

An Israeli study identifies associations between the use of cannabinoids and terpenes for symptoms of attention deficit hyperactivity disorder (ADHD).

Possible therapeutic applications of cannabis in the neuropsychopharmacology field.

Authors: Javier Fernández-Ruiz, Ismael Galve-Roperh, Onintza Sagredo, Manuel Guzmán
European Neuropsychopharmacology, 10 February 2020

Cannabis use induces a plethora of actions on the CNS via its active chemical ingredients, the so-called phytocannabinoids. These compounds have been frequently associated with the intoxicating properties of cannabis preparations. However, not all phytocannabinoids are psychot…

Response to UK Medical Cannabis Guidelines

Physicians from the UK give their critiques of recent medical cannabis regulations, noting the narrow window of qualifying conditions that do not include chronic pain, as well as advocating for the use of lower-cost, whole-plant flowers for patients.